By the Top Tier Newswire AI Desk · September 2, 2026 at 4:15 PM ET · reviewed against 1 wire stories
SL SCIENCE HLDG LTD (SLBT) is up +18.64% in the latest session. Our newswire has captured 1 story on SLBT across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 67/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why SLBT stock is up today
SLBT stock rose 18.64 percent to $3.31 on Monday, driven by the company's recent ringing of the Nasdaq bell and a series of developments in its biomedical research. The stock opened with a 2.2 percent gap up and reached an intraday high of $3.37 before closing near that level. The session marked an active day for the stock, with volume at 0.1 million shares traded, which is 0.2 times the 3-month daily average.
What Happened
SL Science Holding Limited marked a milestone as it rang the Nasdaq bell, capping an active first quarter as a publicly traded company. The event occurred amid a backdrop of recent scientific and regulatory progress, including the filing of a new drug master file with the U.S. FDA for exosomes derived from gamma delta T cells. Additionally, the company announced the publication of a peer-reviewed article in 'Biomedicines' outlining a development framework for γδ T cell therapy in glioblastoma. These developments appear to have generated investor interest and contributed to the stock's significant upward movement.
What The Data Shows
The stock's fundamentals remain mixed. It has a market cap of $1.5 billion and is unprofitable, with an EPS of -0.64 for the trailing twelve months. However, revenue has surged by 282.7 percent TTM, and the stock's 52-week range is between $2.51 and $14.50. On Monday, the stock also printed three fresh 52-week lows and thirteen 52-week highs. The intraday session showed a strong reversal from a low of $2.66 to a high of $3.37, indicating a sharp reversal in sentiment during the day.
What To Watch
Investors should continue to monitor the company's progress in its FDA-related filings and peer-reviewed research developments. The stock's recent performance suggests heightened interest, and further corporate updates could influence future price action.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
SLBT · Sep 2 session (5-min) · +11.47% vs prior close · updated 8:45 PM ETAI sentiment, last 36h · averaged over 1 story · 67/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
10d agoBusiness InsiderBULLISH 67General
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and gene therapies,...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →